Fragasso Financial Advisors’s Novartis NVS Stock Holding History

Fragasso Financial Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Buy	1,556 +16	+1%	+$2.4K	0.01%	324
2026 Q1	$235K	Buy	+1,540	New	+$236K	0.01%	294
2020 Q1	–	Sell	-3,850	Closed	-$365K	–	131
2019 Q4	$365K	Hold	3,850	–	–	0.06%	107
2019 Q3	$335K	Hold	3,850	–	–	0.06%	100
2019 Q2	$352K	Buy	+3,850	New	+$326K	0.07%	99
2015 Q1	–	Sell	-14,216	Closed	-$1.18M	–	57
2014 Q4	$1.18M	Sell	14,216 -186	-1%	-$15.4K	1%	28
2014 Q3	$1.21M	Buy	14,402 +2,089	+17%	+$169K	0.95%	21
2014 Q2	$999K	Buy	12,313 +203	+2%	+$16K	0.88%	30
2014 Q1	$923K	Hold	12,110	–	–	0.95%	33
2013 Q4	$872K	Buy	+12,110	New	+$842K	0.78%	35

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fragasso Financial Advisors's NVS Position: Q2 2026 in Review

Fragasso Financial Advisors increased its Novartis (NVS) stake by 1% in Q2 2026, buying an estimated $2.4K and bringing the position to 1,556 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #324.

Fragasso Financial Advisors first reported a position in NVS in Q4 2013 and has held it in 10 quarters since. The position peaked at $1.21M in Q3 2014. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Fragasso Financial Advisors held 1,556 shares of Novartis worth $244K as of Q2 2026.
Fragasso Financial Advisors bought 16 Novartis shares in Q2 2026, an estimated $2.4K.
Novartis made up 0.01% of Fragasso Financial Advisors's portfolio in Q2 2026, its #324 holding.
Fragasso Financial Advisors first reported a position in Novartis in Q4 2013 and has held it in 10 quarters since.
Fragasso Financial Advisors's Novartis position peaked at $1.21M in Q3 2014.
1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.